Evaluating the Efficacy and Safety of Deoxycholic Acid Injection in Reduction of Flank Fat
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Navid Namakizadeh Esfahani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Deoxycholic Acid, Subcutaneous Fat, Cosmetic Techniques. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Espad Pharmed Darou Company.
Abstract (Originalsprache)
Background
Deoxycholic acid (DCA) injection is a noninvasive method for localized fat reduction, offering lower risks compared to invasive techniques. This study evaluates the safety and efficacy of DCA injections for reducing flank fat.
Aims
We assessed the efficacy and safety of DCA injections for flank fat reduction over a 12‐week period using imaging, anthropometric data, Global Aesthetic Improvement Scale (GAIS) scoring, participant satisfaction, and standardized adverse event reporting. Patients/Methods Adults aged 21–65 years with mild to moderate flank fat (≥ 2 cm) received two sessions of 10 mg/mL DCA injections, 6 weeks apart. Standardized ultrasound and caliper measurements were performed prior to each session. Injections were administered at 0.1–0.15 mL per 1 × 1 cm 2 area, with a maximum of 2 mL per flank per session, following standardized marking and injection protocols.
Results
Thirty participants (mean age 34.9 years; 86.7% female) completed the study. By Week 12, 86.7% showed aesthetic improvement based on GAIS score, with significant reductions in waist circumference and fat thickness (measured using caliper and ultrasound; p < 0.001). The procedure was generally safe, with most adverse events being mild to moderate and limited to the injection site.
Conclusion
DCA injections effectively reduced localized flank fat after two treatment sessions, resulting in significant aesthetic improvements. Adverse events were mostly mild and manageable, with no serious complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
- Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran.
- Department of Radiology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Medical Department, Orchid Pharmed Company, Tehran, Iran.
- CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran.
ORCID-Profile: Navid Namakizadeh Esfahani, Maryam Nasimi, Hamidreza Mahmoudi, Kamran Balighi
Förderung
- Espad Pharmed Darou Company
Zitieren
APA
Namakizadeh Esfahani, N., Khorasanizadeh, F., Ehsani, A., Nasimi, M., Mahmoudi, H., Kafi, H., Sabzvari, A., Gholami, H., Saeedi, K., & Balighi, K. (2025). Evaluating the Efficacy and Safety of Deoxycholic Acid Injection in Reduction of Flank Fat. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70436
Vancouver
Namakizadeh Esfahani N, Khorasanizadeh F, Ehsani A, Nasimi M, Mahmoudi H, Kafi H, et al. Evaluating the Efficacy and Safety of Deoxycholic Acid Injection in Reduction of Flank Fat. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70436
BibTeX
@article{NamakizadehEsfahani2025,
author = {Namakizadeh Esfahani, Navid and Khorasanizadeh, Faezeh and Ehsani, Amirhoushang and Nasimi, Maryam and Mahmoudi, Hamidreza and Kafi, Hamidreza and Sabzvari, Araz and Gholami, Hoshyar and Saeedi, Keysan and Balighi, Kamran},
title = {Evaluating the Efficacy and Safety of Deoxycholic Acid Injection in Reduction of Flank Fat},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70436}
}
EUVIMED